Pipeline Progress

Products	Indication	Discovery	Pre-clinical	Phase 1	Phase 2	Phase 3	BE	NDA	Pre-clinical	Partnership	Details
Patented Biopharmaceutical Products
Metabolic
Bogutai®	Osteoporosis									Self-R&D
UOS003(oral PTH)	Osteoporosis									Self-R&D
Uni-GLP-1(liquid)	Type 2 Diabetes									Self-R&D
Uni-GLP-1(liquid)	Obesity									Self-R&D
UDS003(oral GLP-1)	Type 2 Diabetes									Self-R&D
Ophthalmology
UB101	AMD
UB102	AMD
Wound Care
UB104	Wound Healing

Products	Discovery	Production Development	Formulation Development	Marketed	Partnership	Details
Advanced Skincare Raw Materials
Fibronectin
Beauty peptides
Collagen
Microecological skin-care
Stem cell exosome

Product	Indication	Information survey	Preliminary preparations	Research on prescription technology	Quality research	Stability study	Pharmacology and Toxicology Research	ANDA	Marketed	Remark	Details
High Value Generic Drugs
Endocrinology
Diquafosol sodium eye drops	Dry eye									API Manufacturer

Patented Biopharmaceutical Products
Metabolic
Products	Bogutai®	UOS003 (oral PTH)	Uni- GLP-1 (liquid)	Uni- GLP-1 (liquid)	UDS003 (oral GLP-1)
Indication	Osteoporosis	Osteoporosis	Type 2 Diabetes	Obesity	Type 2 Diabetes
Discovery
Pre-clinical
Phase 1
Phase 2
Phase 3
BE
NDA
Time to Market
Partnership	Self-R&D	Self-R&D	Self-R&D	Self-R&D	Self-R&D
Details

Ophthalmology			Wound Care
Products	UB101	UB102	UB104
Indication	AMD	AMD	Wound Healing
Discovery
Pre-clinical
Phase 1
Phase 2
Phase 3
BE
NDA
Time to market
Partnership
Details

Advanced Skincare Raw Materials
Products	Fibron- ectin	Beauty peptides	Collagen	Microeco- logical skin-care	Stem cell exosome
Discovery
Production Development
Formulation Development
Time to market
Partnership
Details

High Value Generic Drugs
Ophthalmology
Products	Diquafosol sodium eye drops
Indication	Dry eye
Information survey
Preliminary preparations
Research on prescription technology
Quality research
Stability study
Pharmacology and Toxicology Research
ANDA
Time to market
Partnership	API Manufacturer
Details